Lilly: Eli Lilly shares surge on new obesity pill data. What it means for the stock from here
Jim Cramer said Eli Lilly's new trial data has turned the obesity market into a 'one-horse race.'
Read full article »
Lilly is a Massachusetts-based pharmaceutical company that develops, produces and markets pharmaceutical products for healthcare professionals, patients and consumers.
Read more